Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × GIST × Imatinib Mesylate × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Neoplasms 3 Leukemia 3 Gastrointestinal Stromal Tumors 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myeloid, Chronic-Phase 1 Hematologic Neoplasms 1 GIST 1

Interventions

Surgical Procedures, Operative 1 Imatinib Mesylate 1 Coal Tar 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05895942 2023-06-09

EMMBKM

Xijing Hospital

GIST

Data powered by HemOnc (CC BY 4.0) Colophon ⚡